[1]
Kusama, H. et al. 2025. Should All Low-Grade Ductal Carcinoma In Situ Be Excised? Implications and Challenges of the COMET Trial. World Journal of Oncology. 16, 2 (Mar. 2025), 239–241. DOI:https://doi.org/10.14740/wjon2562.